Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Novel Roche peptides useful for bone disorders

April 13, 1999

Genentech's NGF disappointing in phase III trial

April 13, 1999

Small-molecule thrombopoietic compounds in development at Kyowa Hakko

April 13, 1999

Sertoli and JDF enter cellular therapy collaboration for type I diabetes

April 12, 1999

Selective, orally active beta3-adrenoceptor agonists identified at Merck

April 9, 1999

New class of potent, selective human glucagon receptor antagonists presented by Merck

April 9, 1999

Peptidomimetic GH secretagogues synthesized under Japanese-U.S. collaboration

April 9, 1999

Inhibitors of MTP from Wakunaga claimed for lipoprotein disorders

April 8, 1999

Generex's buccal insulin effective in short-term clinical trials

April 8, 1999

U.S. patent issues to RCT for novel diabetes vaccine

April 8, 1999

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...